Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | BGB-B2033 |
Synonyms | |
Therapy Description |
BGB-B2033 is a bispecific antibody targeting TNFRSF9 (4-1BB) and GPC3, which potentially induces killing of GPC3-expressing tumor cells and antitumor activity (Cancer Res (2025) 85 (8_Supplement_1): 6009). |